Disparate Interferon Signaling and Shared Aberrant Basaloid Cells in a Single-Cell Comparison of Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease

被引：0
|
作者：
Valenzi, E. [1 ]
Tabib, T. [2 ]
Papazoglou, A. [2 ]
Sembrat, J. [1 ]
Bittar, H. Trejo [3 ]
Rojas, M. [1 ]
Lafyatis, R. [2 ]
机构：
[1] Univ Pittsburgh, Pulm Allergy & Crit Care Med, Pittsburgh, PA USA
[2] Univ Pittsburgh, Rheumatol & Clin Immunol, Pittsburgh, PA USA
[3] Univ Pittsburgh, Pathol, Pittsburgh, PA USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4355
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Disparate Interferon Signaling and Shared Aberrant Basaloid Cells in Single-Cell Profiling of Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease
    Valenzi, Eleanor
    Tabib, Tracy
    Papazoglou, Anna
    Sembrat, John
    Trejo Bittar, Humberto E.
    Rojas, Mauricio
    Lafyatis, Robert
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [2] Severity, Predictors, And Impact Of Cough In Idiopathic Pulmonary Fibrosis And Systemic Sclerosis-Associated Interstitial Lung Disease
    Cheng, J.
    Wilcox, P. J.
    Corte, T. J.
    Murphy, D.
    Hague, C. J.
    Ryerson, C. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [3] Molecular Mechanisms Underlying Systemic Sclerosis-Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis: an Update
    Verma, Priyanka
    Bale, Swarna
    Varga, John
    Bhattacharyya, Swati
    CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2023, 9 (04) : 221 - 235
  • [4] SAFETY PROFILE OF NINTEDANIB IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE AND IDIOPATHIC PULMONARY FIBROSIS
    Highland, Kristin
    Distler, Oliver
    Gahlemann, Martina
    Azuma, Arata
    Fischer, Aryeh
    Mayes, Maureen
    Raghu, Ganesh
    Sauter, Wiebke
    Girard, Mannaig
    Kohlbrenner, Veronika
    Clerisme-Beaty, Emmanuelle
    Stowasser, Susanne
    Kuwana, Masataka
    Maher, Toby M.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 200 - 200
  • [5] The Impact of Progressive Pulmonary Fibrosis in Systemic Sclerosis-Associated Interstitial Lung Disease
    Martin-Lopez, Maria
    Carreira, Patricia E.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (20)
  • [6] Clinical Impact of Progressive Pulmonary Fibrosis in Systemic Sclerosis-associated Interstitial Lung Disease
    Han, Kyung-Il
    Hwang, Jung Hwa
    Nam, Bo Da
    Song, Jin Woo
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [7] Progress in progressive pulmonary fibrosis: biomarkers of systemic sclerosis-associated interstitial lung disease
    Takada, Toshinori
    RHEUMATOLOGY, 2024, 63 (11) : 2907 - 2908
  • [8] Single-cell analysis reveals fibroblast heterogeneity and myofibroblasts in systemic sclerosis-associated interstitial lung disease
    Valenzi, Eleanor
    Bulik, Melissa
    Tabib, Tracy
    Morse, Christina
    Sembrat, John
    Bittar, Humberto Trejo
    Rojas, Mauricio
    Lafyatis, Robert
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (10) : 1379 - 1387
  • [9] Single-Cell Analysis Reveals Fibroblast Heterogeneity and Myofibroblasts in Systemic Sclerosis-Associated Interstitial Lung Disease
    Valenzi, E.
    Bulik, M.
    Tabib, T.
    Morse, C.
    Sembrat, J.
    Bittar, H. Trejo
    Rojas, M.
    Lafyatis, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [10] Tomographic Fibrosis Score in the Patients with Systemic Sclerosis-Associated Interstitial Lung Disease
    Ozmen, Mustafa
    Gumus, Cesur
    Otman, Eda
    Sinci, Kazim Ayberk
    Aysin, Idil Kurut
    Solmaz, Dilek
    Akar, Servet
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2023, 10 (03) : 107 - 113
12345